Separately, GWAS evidence suggests that tau may play a role in the pathogenesis of synucleinopathies, such as Parkinson’s disease and multisystem atrophy, as well as certain forms of epilepsy, such as Dravet’s syndrome (29). This evidence concerns the gene MAPT and Parkinson disease.